Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N. Bown N, et al. Among authors: Lastowska M. N Engl J Med. 1999 Jun 24;340(25):1954-61. doi: 10.1056/NEJM199906243402504. N Engl J Med. 1999. PMID: 10379019 Clinical Trial.
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Łastowska M, Viprey V, Santibanez-Koref M, Wappler I, Peters H, Cullinane C, Roberts P, Hall AG, Tweddle DA, Pearson AD, Lewis I, Burchill SA, Jackson MS. Łastowska M, et al. Oncogene. 2007 Nov 22;26(53):7432-44. doi: 10.1038/sj.onc.1210552. Epub 2007 May 28. Oncogene. 2007. PMID: 17533364
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?
Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG, Plantaz D. Vandesompele J, et al. Among authors: Lastowska M. Med Pediatr Oncol. 2001 Jan;36(1):5-10. doi: 10.1002/1096-911X(20010101)36:1<5::AID-MPO1003>3.0.CO;2-E. Med Pediatr Oncol. 2001. PMID: 11464905 Clinical Trial.
Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.
Lastowska M, Van Roy N, Bown N, Speleman F, Roberts P, Lunec J, Strachan T, Pearson AD, Jackson MS. Lastowska M, et al. Med Pediatr Oncol. 2001 Jan;36(1):20-3. doi: 10.1002/1096-911X(20010101)36:1<20::AID-MPO1006>3.0.CO;2-E. Med Pediatr Oncol. 2001. PMID: 11464884 Clinical Trial.
17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD; U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Bown N, et al. Among authors: Lastowska M. Med Pediatr Oncol. 2001 Jan;36(1):14-9. doi: 10.1002/1096-911X(20010101)36:1<14::AID-MPO1005>3.0.CO;2-G. Med Pediatr Oncol. 2001. PMID: 11464868 Clinical Trial.
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.
Lastowska M, Cullinane C, Variend S, Cotterill S, Bown N, O'Neill S, Mazzocco K, Roberts P, Nicholson J, Ellershaw C, Pearson AD, Jackson MS; United Kingdom Children Cancer Study Group and the United Kingdom Cancer Cytogenetics Group. Lastowska M, et al. J Clin Oncol. 2001 Jun 15;19(12):3080-90. doi: 10.1200/JCO.2001.19.12.3080. J Clin Oncol. 2001. PMID: 11408505
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Bénard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, Caron H, Matthay KK, Feuerstein BG, Speleman F. Plantaz D, et al. Among authors: Lastowska M. Int J Cancer. 2001 Mar 1;91(5):680-6. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1114>;2-r. Int J Cancer. 2001. PMID: 11267980
44 results
Jump to page